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Abstract Prion disease incubation time in mice is deter-
mined by many factors including genetic background. The
prion gene itself plays a major role in incubation time;
however, other genes are also known to be important. Whilst
quantitative trait loci (QTL) studies have identified multiple
loci across the genome, these regions are often large, and
with the exception of Hectd2 on Mmu19, no quantitative trait
genes or nucleotides for prion disease incubation time have
been demonstrated. In this study, we use the Northport
heterogeneous stock of mice to reduce the size of a
previously identified QTL on Mmu15 from approximately
25 to 1.2 cM. We further characterised the genes in this
region and identify Cpne8, a member of the copine family, as
the most promising candidate gene. We also show that
Cpne8 mRNA is upregulated at the terminal stage of disease,
supporting a role in prion disease. Applying these techniques
to other loci will facilitate the identification of key pathways
in prion disease pathogenesis.
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Introduction
Transmissible spongiform encephalopathies or prion dis-
eases are progressive neurodegenerative disorders for
which there is no effective treatment and are invariably
fatal. They occur in several mammalian species including
scrapie in sheep, bovine spongiform encephalopathy
(BSE) in cattle and Creutzfeldt–Jakob disease in humans.
Although there is variation between disease types, they are
characterised by a clinically silent long incubation period
and share the neuropathological features of neuronal loss,
spongiform change (vacuolation) and deposition of an
abnormal form of the prion protein. Prion diseases are
naturally and experimentally transmissible, including to
laboratory mice.
Experimental transmission of prions to different strains
of inbred mice shows highly reproducible variation in
incubation time, reflecting a strong genetic influence [1–4].
The similarities between the mouse and human genome,
and conservation of these diseases across mammalian
species, suggest that the identification of quantitative trait
genes in mice will not only highlight common disease
pathways and new therapeutic targets but will also identify
susceptibility genes in human. The main genetic determi-
nant of incubation time and susceptibility in both mouse
and humans is variation in the prion gene (Prnp) itself. In
mice, Prnp
a (Leu-108, Thr-189) and Prnp
b (Phe-108, Val-
189) mice have short and long incubation times, respec-
tively [4, 5]. However, prion transmissions to different
Prnp
a allele mice show significant variation in incubation
time, suggesting that other genes are also important [3, 4,
6]. Quantitative trait studies using a variety of mouse
crosses and prion strains have successfully identified
several loci across the genome [7–11]; however, the
underlying quantitative trait genes (QTG) for these
regions have not yet been identified. In these crosses,
no quantitative trait locus (QTL) for prion disease
incubation time was detected on Mmu19; however, using
a heterogenous stock of mice, we previously identified
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backcross inoculated intracerebrally with BSE prions,
Manolakou et al. [10] identified a QTL of significant
linkage on Mmu15. The two-way cross resulted in low-
resolution mapping such that the interval spans approxi-
mately 25 cM and is therefore too large for individual
candidate gene analysis. Several strategies are available
for fine mapping including the use of heterogeneous
stocks (HS) of mice [13–15]. The Northport HS was
produced from semi-randomly mating eight different
parental strains (A/J, AKR/J, BALB/cJ, CBA/J, C3H/
HeJ, C57BL/6J, DBA/2J and LP/J) over multiple gener-
ations [16]. This breeding scheme results in offspring with
chromosomes that contain multiple recombinations, mod-
elling an outbred population with the advantage that all
the parental alleles are known. In combination with the
development of appropriate multipoint linkage pro-
grammes, HS populations have successfully been used to
obtain mapping resolution of 1–2c M[ 16–19]. In this
study, we use the Northport HS to refine the region of
linkage on Mmu15 and identify Cpne8 as a potential
quantitative trait gene for prion disease incubation time.
Materials and methods
Mice and prion infection
RIIIS/J mice were obtained from the Jackson Laboratory
(Bar Harbor, Maine, USA), and all other inbred lines
were obtained from Harlan, UK. Twenty-eight pairs of
Northport HS mice were obtained from R. Hitzemann
(Portland, Oregon, USA) at generation 35. The offspring
were mated semi-randomly, avoiding shared grandpar-
ents, to obtain 49 mating pairs. Approximately 1,000
offspring (generation 37) were used for inoculation.
Mice were anaesthetised with isofluorane/O2 and inocu-
lated intracerebrally into the right parietal lobe with 30 μl
Chandler/RML prions as previously described [7]. Incu-
bation time was calculated retrospectively after a definite
diagnosis of prion disease had been made and defined as
the number of days from inoculation to the onset of
clinical signs [20]. All procedures were conducted in
accordance with institutional and UK regulations on
animal welfare.
Genotyping
DNA was extracted from 0.5 cm tail biopsies using a
Promega DNA extraction kit and resuspended in 50 μlT E
(10 mM Tris–HCL, 1 mM EDTA, pH 7.5). A 1:10 dilution
of this stock was used as template for subsequent PCRs.
Microsatellites were selected from the UCSC Mouse
Genome Browser (http://genome.ucsc.edu)a n dM o u s e
Genome Informatics web site (www.informatics.jax.org)
and checked that they were polymorphic within the parental
strains of the HS. Twenty microsatellite markers from
Mmu15,( D15Mit234-D15Mit43 (Electronic supplementary
material, Table 1), with an intermarker distance of ∼1–
3 cM, were genotyped in approximately 400 animals which
represent the extreme 20% of both sides of the incubation
time distribution. Fluorescently labelled and standard
oligonucleotides were synthesised by Sigma-Genosys.
PCR reactions were all carried out in 5 μl on 96-well
plates using MegaMix Blue (Microzone Ltd.) according to
the manufacturer’s instructions using 5 pmol of each
primer. PCR conditions were determined empirically, but
in general, cycling conditions using a PTC-225 (MJ
Research) thermal cycler were as follows: 94°C for
10 min; 94°C 30 s, 55°C 30 s, 72°C 30 s for 35 cycles;
72°C for 5 min. Products of appropriate size and fluoro-
chrome were pooled before further processing. Reactions
were ethanol-precipitated, washed in 70% ethanol and
resuspended in a total of 10 μl including 5.8 μl Mega-
BACE loading solution (GE Healthcare) and 0.2 μl Mega-
BACE ET400-R size standard (GE Healthcare). Dilution
(1/10) in MegaBACE loading solution was used for
analysis. Fragments were heat-denatured at 94°C for
2 min before loading onto a MegaBACE1000 capillary
sequencer (GE Healthcare). Samples were injected at 3 kV
for 45 s and run at 10 kV for 60 min. Fragment sizes were
analysed using Genetic Profiler v1.1 (GE Healthcare).
Multipoint linkage analysis was carried out using HAPPY
(http://www.well.ox.ac.uk/happy).
Primers and probes for genotyping SNPs (Electronic
supplementary material, Table 4) were designed using
criteria defined by Applied Biosystems and PrimerExpress
software (Applied Biosystems). MGB probes labelled with
either Vic or Fam were purchased from Applied Biosys-
tems, and primers for amplification were obtained from
Sigma-Genosys. All reactions were carried out in 5 μl
(5 pmol of each primer and 1 pmol of each probe) using the
Allelic Discrimination function on a 7500 Fast real-time
PCR system (Applied Biosystems) using QuantiTect probe
PCR kit (Qiagen). Conditions were 95°C for 5 min; 95°C
15 s, 60°C 60 s for 40 cycles.
Sequencing
Genomic DNA for the parental strains were obtained from
the Jackson Laboratory (Bar Harbor, Maine, USA).
Genomic sequence and intron/exon structure for each gene
was established using the UCSC (http://genome.ucsc.edu/)
and ENSEMBLE (http://www.ensembl.org/index.html) ge-
nome browsers. PCR products were designed to cover the
open reading frame, 5′ and 3′ untranslated region, intron–
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defined by the literature for each gene or as predicted by
PROSCAN. Primers were designed using Primer 3 (http://
frodo.wi.mit.edu/). PCR products were generated in 25 μl
as above with 10 pmol of each primer. Forty cycles were
carried out as above except for the annealing and extension
steps of 60°C 45 s, 72°C 60 s. PCR products were cleaned
using Microclean (Microzone Ltd.) according to the
manufacturer’s instructions and resuspended in H2O. PCR
product (100–200 ng) was added to a 15-μl sequencing
reaction including 5 pmol of either the forward or reverse
primer, 1 μl BigDye Terminator v1.1 cycle sequencing kit
(Applied Biosystems) and 5 μl Better buffer (Microzone
Ltd.). Cycling conditions were 95°C 30 s, 50°C 15 s, 60°C
120 s for 30 cycles. Reactions were ethanol-precipitated as
above and resuspended in 10 μl MegaBACE loading
solution. Samples were injected at 3 kV for 40 s and run
at 9 kV for 100 min on a MegaBACE1000 capillary
sequencer.
RNA extraction and quantitative RT-PCR
RNA was extracted from whole brains from either
uninfected or RML terminally sick mice. Tissue was
homogenised using a Ribolyser according to the manufac-
turer’s instructions. RNAwas prepared using either RNeasy
Maxi (Qiagen) kit or TRIreagent (Ambion) according to the
manufacturer’s instructions. Samples were treated with
DNaseI (Qiagen) and purified further using RNeasy Mini
(Qiagen) columns according to the manufacturer’s instruc-
tions. Four micrograms total RNA was reversed-transcribed
with AMV reverse transcriptase and random primers from
the Reverse Transcription System (Promega) according to
the manufacturer’s instructions. Reactions with no reverse
transcription were also carried out for each sample to
ensure no genomic DNA contamination. Cpne8 quantitative
PCR was carried out on a 7500 Fast real-time PCR system
(Applied Biosystems) in a total volume of 15 μl using 1 μl
cDNA (200–300 ng) and RoxMegaMixGold (Microzone
Ltd.) according to the manufacturer’s instructions. Primers
(6 pmol) F-5′-CGCCGTACACCCCTCCTA-3′,R - 5 ′-
GTGTGAGGGACATCAGCATCTG-3′ and probe (3 pmol)
5′-Fam-CTGCAGACGCAAATATGACCACGC-Tamra-3′
were designed using PrimerExpress software (Applied
Biosystems) and supplied by Sigma Genosys. Endogenous
controls (GAPDH and β-actin) were VIC-labelled and
supplied as a kit by Applied Biosystems. Primers and
probe (supplied by Applied Biosystems) for an additional
endogenous control, Thy-1, were designed and used as
above. Thy-F-5′-CAGGCACCCTTGGGATACC-3′;T h y -
R-5′-TGGAACTATATCCCGACCAACCT-3′; probe
5′-Vic-ACGTACCGCTCCCGCGTCACC-Tamra-3′.E n -
dogenous controls were duplexed with the Cpne8 reaction
according to the manufacturer’s instructions (GAPDH and
β-actin) or for Thy-1 using the same primer and probe
concentrations as for Cpne8. All reactions were carried out
in triplicate using the following cycling conditions: 95°C
5 min; 95°C 15 s, 60°C 60 s for 40 cycles.
Results
A previous study identified a 25-cM region on Mmu15
linked to BSE prion incubation time in mice [10]. To
reduce this interval, we used the Northport HS of mice.
The original cross used C57BL/FaDk and RIII/FaDk
mice which are not present in the Northport HS; however,
we reasoned that the C57BL/6J alleles present in the HS
m i c ew o u l db ear e a s o n a b l es u b s t i t u t ef o rt h eC 5 7 B L /
FaDk allele. Primary passage of BSE prions across the
species barrier from cattle to mice results in incubation
times in excess of 400 days, which can be very variable
and frequently results in a less than 100% attack rate. To
avoid these issues, we used the Chandler/RML mouse
adapted scrapie prion strain which was derived originally
from goat scrapie but has been passaged multiple times in
mice [21] and no longer presents a species barrier to mice.
Although it is possible that the Mmu15 QTL is specific to
the BSE strain of prions and might not be relevant in
mouse scrapie, our ultimate goal is to identify candidate
genes that play a role in the fundamental processes of
prion disease and are therefore likely to be independent of
prion strain.
Approximately 1,000 HS mice at generation 37 were
inoculated intracerebrally with Chandler/RML prions.
Incubation times (in days) were determined (n=1,052) and
were used as the quantitative trait. The incubation times
conformed to a normal distribution (Anderson–Darling
normality test) with a mean of 147±15 (SD) with a range
of 103–229 days, thus confirming that both “long” and
“short” incubation time alleles segregate in the population.
To reduce the amount of genotyping, we analysed the mice
from the extreme 20% of both ends of the incubation time
distribution (approximately n=400) as this contains most of
the power available in the cross. Twenty microsatellite
markers from Mmu15 (D15Mit234–D15Mit43) at approxi-
mately 1–3 cM intermarker distances were genotyped in the
HS mice (Electronic supplementary material, Table 1).
Multipoint linkage analysis was carried out using the
HAPPY programme (http://www.well.ox.ac.uk/happy) [17]
which identified a peak of linkage at the interval
D15Mit241–D15Mit262 (−logP=4.52) and the adjacent
interval D15Mit262–D15Mit34 (−logP=4.48; Fig. 1a and
Electronic supplementary material, Table 1). Significant
linkage was taken as −logP>3 as defined by a permutation
test (n=1,000) carried out by HAPPY. This QTL explains
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reported for BSE prions. Based on information from the
UCSC Genome Browser NCBI build 37 (http://genome.
ucsc.edu), the region from D15Mit241–D15Mit34 is 1.2 cM
(3.6 Mb), which represents a considerable reduction from
the original locus and is small enough for a candidate gene
approach to be feasible.
Current database interrogation (NCBI build 37) esti-
mates that the D15Mit241–D15Mit34 interval contains 39
known transcripts. D15Mit241–D15Mit262 contains only
one Genbank transcript (AK020896), which contains three
exons with the potential to encode a protein of 70 residues
and is of unknown function. D15Mit241 maps within the
intron 2 of this transcript. Sequencing AK020896 in the HS
parental strains identified two polymorphisms in exons 1
and 2, respectively. These are likely to represent SNPs in
the 5′UTR and map proximal to D15Mit241. We did not
exclude AK020896 on this basis; however, we extended
our analysis to include the D15Mit262–D15Mit34 interval
(3.47 Mb). This contains 38 transcripts of which we
sequenced 29 in the HS parental strains (see Electronic
supplementary material, Table 2 for a list of sequenced
genes). These 29 genes include all genes in the region
predicted to have a role in the central nervous system.
Excluded genes included those with known non-CNS
tissue-specific functions. Sequencing was not exhaustive,
and we focused primarily on the cDNA transcript (ORF, 5′
and 3′UTRs), intron–exon boundaries and potential pro-
moters as defined by the literature for each gene or
PROSCAN (http://www-bimas.cit.nih.gov/molbio/pro
scan). Most genes proved not to be very polymorphic in
the HS parental strains, with only 88 polymorphisms being
identified across the whole region. Most genes contained
one or two polymorphisms, but the greatest number were
seen primarily in Rabl2a (33) and Cpne8 (38). All variants
were assessed using a function of HAPPY that uses
progenitor strain information to identify quantitative trait
nucleotides by reconstructing ancestral haplotypes [22].
The most significant candidates from this analysis were:
Rabl2a (−logP=6.02), Syt10 (−logP=5.4) and Cpne8
(−logP=5.1). A graphic display from HAPPY is shown in
Fig. 1b, and details of all identified individual SNPs are
shown in Electronic supplementary material, Table 3. For
Rabl2a, the most significant strain distribution pattern
(Table 1) is seen for two SNPs, one of which is a non-
synonymous amino acid change (S276G). For Syt10, only
Fig. 1 HAPPY multipoint linkage analysis for D15Mit234–
D15Mit43. Results are displayed on the y-axis as −log of the P value
with cM along Mmu15 on the x-axis (a) and Mb along Mmu15 on the
x-axis for b. a Log probability plot (additive model). The peak of
linkage is seen for the interval D15Mit241–D15Mit262 (−logP=4.52)
and the adjacent interval D15Mit262–D15Mit34 (−logP=4.48). These
data are generated by analysis of HS mice (n=400) from both
extremes of the incubation time distribution. For details of intervals,
see Electronic supplementary material, Table 1. b HAPPY analysis
(additive merged model) for all polymorphisms detected in the interval
D15Mit37–D15Mit34. SNPs are derived from sequencing the HS
parental lines and data are analysed according to the methods of
Yalcin et al [22]. Details for individual SNPs are given in Electronic
supplementary material, Table 3. Highly significant SNPs are boxed to
illustrate the associated gene
Strain distribution pattern Genes −logP Comment
(A, C3H, C57, CBA) (AKR, BALB, DBA, LP) Rabl2a 6.02 Exon 7 S276G And 1 3′UTR
(A, AKR,C3H, C57, CBA, LP) (BALB, DBA) Syt10 5.40 Exon 1 G46G
(A, C3H, CBA, LP) (AKR, BALB, C57, DBA) Cpne8 5.11 6 Intronic and 3 3′UTR
Table 1 Most significant strain
distribution patterns
D15Mit241–D15Mit34
−logP values are estimated by
HAPPY based on polymor-
phisms detected in the parental
strains of the HS
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synonymous change in exon 1 (G46G). For Cpne8, nine
significant SNPs were detected, six of which were intronic
and three were seen in the 3′UTR.
To verify these data, we genotyped representative
significant SNPs from Rabl2a, Syt10 and Cpne8 in the
HS animals and analysed the data by ANOVA (Table 2 and
Electronic supplementary material, Table 5). Surprisingly,
the Rabl2a SNP was not significant (P=0.84), but SNPs for
Syt10 (P=0.0019) and Cpne8 (P=0.0002) were both highly
significant. The original linkage data for Mmu15 came from
a C57BLxRIII cross which suggest that if we are detecting
an effect from the same gene in both crosses, then the
functional polymorphism should be present in both crosses.
We therefore sequenced the candidate SNPs in RIIIS/J and
compared this to the C57BL/6J alleles. For the single Syt10
SNP (Gly46Gly), C57BL/6J and RIIIS/J share the same
allele, which suggests that this is unlikely to be the QTN.
For the nine significant Cpne8 variants (six intronic, three
in the 3′UTR), C57BL/6 and RIIIS have different alleles,
which is consistent with Cpne8 being the most promising
candidate gene in this region. No clear function can be
assigned to the Cpne8 SNPs; however, it is possible that
because our sequencing was not exhaustive, we have not
seen the functional SNPs but that they share the same strain
distribution pattern. Using RT-PCR, we examined the
Cpne8 transcript across different mouse strains for splice
variants, but at the level of detection by ethidium bromide-
stained agarose gel, we could not detect any alternative
splicing events (data not shown).
As an additional screening tool, we also looked at the
expression of mRNA by real-time RT-PCR in the HS
parental lines for Cpne8 (Fig. 2a). RNA was extracted from
whole brains of 6- to 8-week-old male mice (except LP).
Samples were analysed by real-time RT-PCR and normal-
ised using the geometric mean of the quantity obtained
from three endogenous controls (GAPDH, β-actin and Thy-
1). To look for genotype-related differential expression, the
strains were grouped according to the most significant
strain distribution pattern seen in Cpne8 as represented by
the 3′UTR SNP (CPNE3UB T/C) where T = A, C3H, CBA
and C = AKR, BALB, C57, DBA. No significant difference
in expression was seen between the two genotypes
(Fig. 2b). We also compared the level of Cpne8 expression
between C57BL/6 (CPNE3UB C) and RIIIS (CPNE3UB
T), and no significant difference was detected (Fig. 2c). In
addition, we compared Cpne8 mRNA expression with
published incubation times for the inbred lines, and no
correlation was observed (R
2=0.28) [3, 4, 23].
To see if Cpne8 mRNA expression is associated with
prion infection, we compared Cpne8 levels in the brains of
uninfected and RML prion infected mice at the terminal
stage of disease (Fig. 2c). A significant increase (×2.5-fold)
was seen in disease in both C57BL/6 (P=2.7×10
−5) and
RIIIS strains (P=7.8×10
−6). No significant difference was
seen between RML-infected C57BL/6 and RIIIS strains.
Discussion
Whilst multiple QTL for prion disease incubation time in
mice have been described, with the exception of Hectd2,n o
candidate genes for these loci have been identified [7–12].
Table 2 Polymorphism genotyping in HS mice
Gene Polymorphism HS p-value (ANOVA)
Rabl2 Exon 7 S276G P=0.8416 (n=567)
Syt10 Exon 1 G46G P=0.0019 (n=403)
Cpne8 Intron 17 A/G P=0.0002 (n=415)
Cpne8 3′UTR T/C P=0.0026 (n=406)
P=0.0007 (n=970)
All polymorphisms were analysed by allele discrimination using a
real-time PCR machine (Applied Biosystems). Full details of the
ANOVA are provided in Electronic supplementary material, Table 5
Fig. 2 Cpne8 mRNA expression. cDNAwas prepared from the whole
brains of uninfected 6- to 8-week-old male mice or mice at the
terminal stages of prion disease (Chandler/RML). All samples were
duplexed for Cpne8 (Fam-label) and an endogenous control GAPDH,
β-actin or Thy-1 (Vic-label). Samples were run in triplicate with n=6
for each mouse strain/group (except CBA where n=3). Mean ± SEM
Cpne8 mRNA expression level is expressed in arbitrary units as
normalised by the geometric mean of the quantity of the endogenous
controls (y-axis). a Parental strains of the HS mice (except LP). b
Mouse strains are grouped by the main significant strain distribution
seen in Cpne8 as represented by the genotype at a 3′UTR SNP
(CPNE3UB T/C; T = A, C3H, CBA; C = AKR, BALB, C57, DBA). c
Comparison of Cpne8 mRNA expression in C57BL/6 and RIIIS/J
mice in normal and RML infected mice. Dark grey and light grey bars
represent uninfected and RML-infected mice, respectively. Significant
differences are seen between normal and terminally sick mice (P=
2.7×10
−5 and P=7.9×10
−6 for C57BL/6 and RIIIS/J, respectively)
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reduced the size of the Mmu15 QTL from approximately 25
to 1.2 cM. Sequence analysis and subsequent testing of the
SNPs identified many genes, with SNPs reaching the
threshold of significance (−logP>3); however, Syt10 and
Cpne8 were identified as the most promising candidate
genes. In studies of this nature, it is not always possible to
eliminate the possibility that genes excluded by us may still
be contributing to the QTL. Further, our sequencing of the
region was not exhaustive, and it is possible that the most
significant strain distribution pattern could be seen in other
genes or intergenic regions.
Although SNPs in both Syt10 and Cpne8 gave highly
significant results, we discounted Syt10 because these were
not polymorphic between C57BL/6 and RIIIS strains. This
was based on the assumption that the quantitative trait gene
and nucleotides are the same in the original C57BL × RIII
backcross and the HS. Although a reasonable assumption, it
is possible that this may not be the case because we used
C57BL/6J mice, and the original cross used C57BL mice
which may harbour differences between them. In addition,
the original QTL was identified in mice inoculated with
BSE prions, whereas we have used mouse-adapted scrapie
prions which are known to be distinct prion strains.
Based on the assumptions detailed above, Cpne8 is the
most promising candidate gene in the region. Highly
significant SNPs were found in the 3′UTR. These SNPs
were not associated with an alteration in mRNA level;
however, it is possible that they influence mRNA structure
and translation efficiency. Although we sequenced the
putative promoter, 5′UTR, ORF and 3′UTR of Cpne8,i t
is possible that we may not have seen the functional SNPs
if these are contained within introns or more distant
regulatory regions.
Differences in mRNA expression levels were not
associated with genotype or incubation time differences;
however, we did see a ×2.5-fold increase in the disease state
independent of mouse strain, suggesting that Cpne8 may be
involved in the disease process.
Little is known about the function of Cpne8; however, it
is a member of the copine family of proteins which are Ca
2+-
dependent phospholipid binding proteins thought to be
involved in membrane trafficking [24]. PrP is a glycosyl-
phosphatidylinositol anchored protein located primarily on
the plasma membrane. During its synthesis, it is trafficked
through the endoplasmic reticulum and Golgi towards the
plasma membrane where it is associated with lipid rafts. PrP
is thought to be constantly recycled from the plasma
membrane through clathrin-mediated endocytosis (for re-
view, see [25]). The cellular location of PrP conversion to the
abnormal form, PrP
Sc, and the importance of these sites in
prion pathogenesis are yet to be fully described. However,
pathogenic mutations of PrP, associated with familial prion
disease, have shown abnormal cellular localisations [26–28].
This suggests that the correct trafficking of PrP is critical and
proteins such as CPNE8 may be important in regulating this
process. Although Syt10 is not a good candidate gene for the
C57BL × RIIIS cross, it is highly significant in the HS, and
interestingly, Syt10 is a member of the synaptotagmin family
which are also thought to be Ca
2+-dependent phospholipid
binding proteins [29].
In conclusion, we believe that Cpne8 is the most promising
candidate gene for the Mmu15 QTL. This is the first example
of a prion disease incubation time QTL being reduced in size
by fine mapping and for a candidate gene to be identified.
Similar approaches applied to other QTL across the genome
should reveal other candidate genes that will elucidate the key
pathways involved in prion disease pathogenesis.
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